Despite receiving equally aggressive treatment, CD8+ T-cells increased rapidly in sepsis patients without ARDS over the course of one week, and these levels were significantly higher than in patients who progressed to ARDS, with this difference remaining evident after two weeks. The gene discussed is CD8A; the disease is acute respiratory distress syndrome.